Chronic pruritus in atopic dermatitis – mechanisms and different ways of treatment, affect on quality of life
DOI:
https://doi.org/10.12775/JEHS.2023.13.04.003Keywords
chronic itch, chronic stress, chronic pruritus, itch treatment, quality of life, mechanism of itchAbstract
Introduction: Pruritus in atopic dermatitis is one of the main symptoms of the disease and the one that causes a significant impact on quality of life. It is important to control itching because it’s not only an unplesant sense. Scratching topically deepen the dermatitis, damages the epidermal barrier causing additional infections possible and makes it harder to acheive a remission of the disease. It is also highly associated with stress and has an impact on mental health of the patient. In this article we present a summary of how pruritus affects the quality of life, mechanisms of pruritus and possible treatment.
Materials and methods: Our work is based on the articles published in PubMed, medical books and websites. We were looking for the key words such as ‘stress and itch’, ‘pruritus treatment’, ‘chronic itch in atopic dermatitis’, ‘itch and quality of life’.
Results: Patients with atopic dermatitis should come under miltidisciplinar treatment to acheive the best possible control of symptoms. This will result in higher quality of life and better mental health of the patient.
Conclusions: There is a high need to develop new targeted medications as contemporary medicine knows a lot more about the mechanism of pruritus. Many new types of treatment are being studied and soon we may have more options to choose in systemic and topical therapy. We should also concetrate more on a mental side of the disease.
References
buabara K, Magyari A, McCulloch CE, Linos E, Margolis DJ, Langan SM. Prevalence of Atopic Eczema Among Patients Seen in Primary Care: Data From The Health Improvement Network. Ann Intern Med. 2019 Mar 5;170(5):354-356. doi: 10.7326/M18-2246. Epub 2018 Dec 4. PMID: 30508419; PMCID: PMC6548682
Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, Berger TG, Bergman JN, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Silverman RA, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27. PMID: 24290431; PMCID: PMC4410183
Frazier W, Bhardwaj N. Atopic Dermatitis: Diagnosis and Treatment. Am Fam Physician. 2020 May 15;101(10):590-598. PMID: 32412211
Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol. 2008 Jan-Feb;25(1):1-6. doi: 10.1111/j.1525-1470.2007.00572.x. PMID: 18304144.
Han L, Ma C, Liu Q, Weng HJ, Cui Y, Tang Z, Kim Y, Nie H, Qu L, Patel KN, Li Z, McNeil B, He S, Guan Y, Xiao B, Lamotte RH, Dong X. A subpopulation of nociceptors specifically linked to itch. Nat Neurosci. 2013 Feb;16(2):174-82. doi: 10.1038/nn.3289. Epub 2012 Dec 23. PMID: 23263443; PMCID: PMC3557753
Moniaga CS, Tominaga M, Takamori K. Mechanisms and Management of Itch in Dry Skin. Acta Derm Venereol. 2020 Jan 15;100(2):adv00024. doi: 10.2340/00015555-3344. PMID: 31940044; PMCID: PMC9129002
Tominaga M, Tengara S, Kamo A, Ogawa H, Takamori K. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis. J Dermatol Sci. 2009 Jul;55(1):40-6. doi: 10.1016/j.jdermsci.2009.03.007. Epub 2009 May 13. PMID: 19443185
Akiyama T, Carstens E. Neural processing of itch. Neuroscience. 2013 Oct 10;250:697-714. doi: 10.1016/j.neuroscience.2013.07.035. Epub 2013 Jul 24. PMID: 23891755; PMCID: PMC3772667
Ikoma A, Fartasch M, Heyer G, Miyachi Y, Handwerker H, Schmelz M. Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch. Neurology. 2004 Jan 27;62(2):212-7. doi: 10.1212/wnl.62.2.212. PMID: 14745056
Mollanazar NK, Smith PK, Yosipovitch G. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out? Clin Rev Allergy Immunol. 2016 Dec;51(3):263-292. doi: 10.1007/s12016-015-8488-5. PMID: 25931325
Tominaga M, Takamori K. Peripheral itch sensitization in atopic dermatitis. Allergol Int. 2022 Jul;71(3):265-277. doi: 10.1016/j.alit.2022.04.003. Epub 2022 May 25. PMID: 35624035
Sanders KM, Akiyama T. The vicious cycle of itch and anxiety. Neurosci Biobehav Rev. 2018 Apr;87:17-26. doi: 10.1016/j.neubiorev.2018.01.009. Epub 2018 Jan 31. PMID: 29374516; PMCID: PMC5845794
Han S, Soleiman MT, Soden ME, Zweifel LS, Palmiter RD. Elucidating an Affective Pain Circuit that Creates a Threat Memory. Cell. 2015 Jul 16;162(2):363-374. doi: 10.1016/j.cell.2015.05.057. PMID: 26186190; PMCID: PMC4512641
Pondeljak N, Lugović-Mihić L. Stress-induced Interaction of Skin Immune Cells, Hormones, and Neurotransmitters. Clin Ther. 2020 May;42(5):757-770. doi: 10.1016/j.clinthera.2020.03.008. Epub 2020 Apr 7. PMID: 32276734.
Capec S, Petrek M, Capec G, Yaremkevych R, Andrashko Y. Psychologic interventions in patients with the chronic dermatologic itch in atopic dermatitis and psoriasis: A step forward with family constellations seminars. Front Med (Lausanne). 2022 Aug 12;9:965133. doi: 10.3389/fmed.2022.965133. PMID: 36035402; PMCID: PMC9411859.
Wei W, Anderson P, Gadkari A, Blackburn S, Moon R, Piercy J, Shinde S, Gomez J, Ghorayeb E. Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis. J Dermatol. 2018 Feb;45(2):150-157. doi: 10.1111/1346-8138.14116. Epub 2017 Nov 13. PMID: 29131384; PMCID: PMC5813133.
Halvorsen JA, Dalgard F, Thoresen M, Bjertness E, Lien L. Itch and pain in adolescents are associated with suicidal ideation: a population-based cross-sectional study. Acta Derm Venereol. 2012 Sep;92(5):543-6. doi: 10.2340/00015555-1251. PMID: 22068440
Maksimović N, Janković S, Marinković J, Sekulović LK, Zivković Z, Spirić VT. Health-related quality of life in patients with atopic dermatitis. J Dermatol. 2012 Jan;39(1):42-7. doi: 10.1111/j.1346-8138.2011.01295.x. Epub 2011 Nov 2. PMID: 22044078.
Hon KL, Kung JSC, Ng WGG, Leung TF. Emollient treatment of atopic dermatitis: latest evidence and clinical considerations. Drugs Context. 2018 Apr 17;7:212530. doi: 10.7573/dic.212530. PMID: 29692852; PMCID: PMC5908267
Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014 Jul;71(1):116-32. doi: 10.1016/j.jaad.2014.03.023. Epub 2014 May 9. PMID: 24813302; PMCID: PMC4326095
Musters AH, Mashayekhi S, Harvey J, Axon E, Lax SJ, Flohr C, Drucker AM, Gerbens L, Ferguson J, Ibbotson S, Dawe RS, Garritsen F, Brouwer M, Limpens J, Prescott LE, Boyle RJ, Spuls PI. Phototherapy for atopic eczema. Cochrane Database Syst Rev. 2021 Oct 28;10(10):CD013870. doi: 10.1002/14651858.CD013870.pub2. PMID: 34709669; PMCID: PMC8552896.
Blauvelt A, Teixeira HD, Simpson EL, Costanzo A, De Bruin-Weller M, Barbarot S, Prajapati VH, Lio P, Hu X, Wu T, Liu J, Ladizinski B, Chu AD, Eyerich K. Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol. 2021 Sep 1;157(9):1047-1055. doi: 10.1001/jamadermatol.2021.3023. Erratum in: JAMA Dermatol. 2022 Feb 1;158(2):219. Erratum in: JAMA Dermatol. 2022 Feb 1;158(2):219. PMID: 34347860; PMCID: PMC8340015
Yang H, Wang J, Zhang X, Zhang Y, Qin ZL, Wang H, Luo XY. Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019 May 1;155(5):585-593. doi: 10.1001/jamadermatol.2019.0008. Erratum in: JAMA Dermatol. 2019 May 22;: PMID: 30916723; PMCID: PMC6507295.
Newsom M, Bashyam AM, Balogh EA, Feldman SR, Strowd LC. New and Emerging Systemic Treatments for Atopic Dermatitis. Drugs. 2020 Jul;80(11):1041-1052. doi: 10.1007/s40265-020-01335-7. PMID: 32519223; PMCID: PMC7281689
Yosipovitch G, Berger T, Fassett MS. Neuroimmune interactions in chronic itch of atopic dermatitis. J Eur Acad Dermatol Venereol. 2020 Feb;34(2):239-250. doi: 10.1111/jdv.15973. Epub 2019 Nov 12. PMID: 31566796; PMCID: PMC7027518
Nakashima C, Yanagihara S, Otsuka A. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors. Allergol Int. 2022 Jan;71(1):40-46. doi: 10.1016/j.alit.2021.10.004. Epub 2021 Nov 21. PMID: 34815171
Ekelem C, Juhasz M, Khera P, Mesinkovska NA. Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review. JAMA Dermatol. 2019 Feb 1;155(2):229-236. doi: 10.1001/jamadermatol.2018.4093. PMID: 30484835
Tubog TD, Harenberg JL, Buszta K, Hestand JD. Use of Nalbuphine for Treatment of Neuraxial Opioid-Induced Pruritus: A Systematic Review and Meta-Analysis. AANA J. 2019 Jun;87(3):222-230. PMID: 31584400
Yosipovitch G, Ständer S, Kerby MB, Larrick JW, Perlman AJ, Schnipper EF, Zhang X, Tang JY, Luger T, Steinhoff M. Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial. J Am Acad Dermatol. 2018 May;78(5):882-891.e10. doi: 10.1016/j.jaad.2018.02.030. Epub 2018 Feb 17. PMID: 29462657.
Welsh SE, Xiao C, Kaden AR, Brzezynski JL, Mohrman MA, Wang J, Smieszek SP, Przychodzen B, Ständer S, Polymeropoulos C, Birznieks G, Polymeropoulos MH. Neurokinin-1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial. J Eur Acad Dermatol Venereol. 2021 May;35(5):e338-e340. doi: 10.1111/jdv.17090. Epub 2021 Jan 7. PMID: 33330999; PMCID: PMC8248080
Kamo A, Tominaga M, Taneda K, Ogawa H, Takamori K. Neurotropin inhibits the increase in intraepidermal nerve density in the acetone-treated dry-skin mouse model. Clin Exp Dermatol. 2013 Aug;38(6):665-8. doi: 10.1111/ced.12100. Epub 2013 Jun 8. PMID: 23745989.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sandra Ostaszewska, Przemysław Morawski, Kinga Augustynowicz, Zuzanna Popińska, Jakub Chrzanowski, Ewa Szymańska, Jan Łoginoff, Kinga Świąder, Filip Pactwa
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 338
Number of citations: 0